You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 64 No. 6, June 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Cerebrovascular Disease
 •Stroke
 •Neurology, Other
 •Drug Therapy
 •Adverse Effects
 •Alert me on articles by topic

Multiple Ischemic Strokes Associated With Use of Recombinant Activated Factor VII

Richard B. Libman, MD; Cordrin Lungu, MD; Thomas Kwiatkowski, MD

Arch Neurol. 2007;64(6):879-881.

Background  Intracerebral hemorrhage is associated with a high rate of mortality and functional disability. For most patients, no treatment other than supportive care has been shown to improve outcome. Preliminary studies suggest that recombinant activated factor VII may limit early hematoma growth and improve functional outcome. However, ischemic complications may occur in some patients.

Objective  To report a case of severe cerebral ischemic complications associated with the use of recombinant activated factor VII.

Design  Case report.

Setting  Tertiary care medical center.

Patient  We describe a patient with ischemic stroke who developed hemorrhagic conversion following tissue plasminogen activator administration.

Interventions  Treatment with recombinant activated factor VII, in addition to standard treatment with cryoprecipitate and platelets.

Main Outcome Measure  Brain imaging showing multiple ischemic strokes.

Results  The patient subsequently developed multiple acute cerebral infarcts in different vascular distributions.

Conclusion  Although the exact relationship between treatment with recombinant activated factor VII and the development of multiple ischemic strokes remains uncertain, this case suggests that a cautious approach to treatment with this agent is warranted until more data are available.


Author Affiliations: Department of Neurology (Dr Libman) and Department of Emergency Medicine (Dr Kwiatkowski), Long Island Jewish Medical Center, and Department of Neurology (Dr Lungu), North Shore Long Island Jewish Health System, New Hyde Park, NY.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.